A multiple gadolinium complex decorated fullerene as a highly sensitive T(1) contrast agent

Area of Science:

• Nanomaterials Science
• Radiology
• Biomedical Engineering

Background:

• Gadolinium-based contrast agents (GBCAs) are crucial for Magnetic Resonance Imaging (MRI).
• Current GBCAs face limitations in relaxivity and potential toxicity.
• Developing novel contrast agents with improved performance is an active research area.

Purpose of the Study:

• To develop a novel, highly efficient T1 contrast agent for MRI.
• To synthesize and characterize a multiple gadolinium complex decorated fullerene (CGDn).
• To evaluate the in vitro and in vivo performance of CGDn as a T1 contrast agent.

Main Methods:

• A simple strategy was employed to synthesize CGDn, a fullerene core decorated with multiple gadolinium complexes.
• T1 relaxivity measurements were performed in vitro.
• In vivo MRI experiments were conducted to assess contrast enhancement.

Main Results:

• The synthesized CGDn exhibited significantly higher T1 relaxivity (approximately 49.7 mM(-1) s(-1)) compared to individual Gd-DOTA.
• CGDn demonstrated excellent T1 contrast enhancement capabilities in both in vitro and in vivo studies.
• The nanostructure of CGDn contributes to its enhanced performance.

Conclusions:

• The developed CGDn represents a promising enhanced T1 MRI contrast agent.
• CGDn offers superior relaxivity and contrast enhancement over conventional agents.
• This strategy provides a new avenue for designing advanced MRI contrast agents.